{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:37:29Z","timestamp":1791862649442,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46928-6","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:25:21Z","timestamp":1775546721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SPG601-associated modulation of resting-state EEG and improvement in executive function in a fragile X syndrome randomized controlled crossover study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ernest V.","family":"Pedapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Vanderklish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella T.","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharron","family":"Gargosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Westerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"4","key":"46928_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/biomedicines13040805","volume":"13","author":"MB van der Lei","year":"2025","unstructured":"van der Lei, M. B. & Kooy, R. F. From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research. Biomedicines 13 (4), 805 (2025).","journal-title":"Biomedicines"},{"key":"46928_CR2","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman, R. J. et al. Fragile X syndrome. Nat. Rev. Dis. Primers. 3, 17065 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"46928_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/brainsci12101276","volume":"12","author":"DB Budimirovic","year":"2022","unstructured":"Budimirovic, D. B. & Protic, D. D. Fragile X syndrome: Recent research updates toward capturing treatments\u2019 improvement in clinical trials. Brain Sci. 12 (10), 1276 (2022).","journal-title":"Brain Sci."},{"key":"46928_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell, J. C. et al. FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism. Cell 146, 247\u2013261 (2011).","journal-title":"Cell"},{"issue":"4","key":"46928_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pediatrneurol.2013.12.001","volume":"50","author":"E Berry-Kravis","year":"2014","unstructured":"Berry-Kravis, E. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. Pediatr. Neurol. 50 (4), 297\u2013302 (2014).","journal-title":"Pediatr. Neurol."},{"key":"46928_CR6","doi-asserted-by":"crossref","unstructured":"Kshatri, A. et al. Differential regulation of BK channels by fragile X mental retardation protein. J. Gen. Physiol. 152 (6), 1\u201317 (2020).","DOI":"10.1085\/jgp.201912502"},{"key":"46928_CR7","doi-asserted-by":"crossref","unstructured":"Short, B. FMRP differentially regulates BK channels. J. Gen. Physiol. 152 (6),  1\u201317 e202012634 (2020).","DOI":"10.1085\/jgp.202012634"},{"issue":"1","key":"46928_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/brain\/awab246","volume":"145","author":"MJ Hurley","year":"2022","unstructured":"Hurley, M. J. et al. Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice. Brain 145 (1), 76\u201382 (2022).","journal-title":"Brain"},{"key":"46928_CR9","doi-asserted-by":"crossref","unstructured":"Zhan, X. et al. Calcium-Dependent Regulation of Neuronal Excitability Is Rescued in Fragile X Syndrome by a Tat-Conjugated N-Terminal Fragment of FMRP. J. Neurosci. 44 (21), 1\u201314 e0136242024 (2024).","DOI":"10.1523\/JNEUROSCI.0136-24.2024"},{"key":"46928_CR10","doi-asserted-by":"publisher","first-page":"15281","DOI":"10.1073\/pnas.0804678105","volume":"105","author":"L Liao","year":"2008","unstructured":"Liao, L. et al. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc. Natl. Acad. Sci. U S A. 105, 15281\u201315286 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"46928_CR11","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1176\/ajp.2006.163.9.1622","volume":"163","author":"F Laumonnier","year":"2006","unstructured":"Laumonnier, F. et al. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am. J. Psychiatry. 163, 1622\u20131629 (2006).","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"46928_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2012.12.018","volume":"77","author":"PY Deng","year":"2013","unstructured":"Deng, P. Y. et al. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 77 (4), 696\u2013711 (2013).","journal-title":"Neuron"},{"issue":"1","key":"46928_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1113\/JP271031","volume":"594","author":"PY Deng","year":"2016","unstructured":"Deng, P. Y. & Klyachko, V. A. Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome. J. Physiol. 594 (1), 83\u201397 (2016).","journal-title":"J. Physiol."},{"issue":"4","key":"46928_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1073\/pnas.1423094112","volume":"112","author":"LK Myrick","year":"2015","unstructured":"Myrick, L. K. et al. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures. Proc. Natl. Acad. Sci. U S A. 112 (4), 949\u2013956 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"13","key":"46928_CR15","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1113\/JP271841","volume":"594","author":"M Griguoli","year":"2016","unstructured":"Griguoli, M., Sgritta, M. & Cherubini, E. Presynaptic BK channels control transmitter release: physiological relevance and potential therapeutic implications. J. Physiol. 594 (13), 3489\u20133500 (2016).","journal-title":"J. Physiol."},{"key":"46928_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-014-0124-6","volume":"9","author":"B Hebert","year":"2014","unstructured":"Hebert, B. et al. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule. Orphanet J. Rare Dis. 9, 124 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"46928_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13229-017-0140-1","volume":"8","author":"LE Ethridge","year":"2017","unstructured":"Ethridge, L. E. et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol. Autism. 8, 22 (2017).","journal-title":"Mol. Autism"},{"key":"46928_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-017-9191-z","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J. Neurodev Disord. 9, 11 (2017).","journal-title":"J. Neurodev Disord"},{"issue":"2","key":"46928_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1471-4159.2010.06938.x","volume":"115","author":"M Martire","year":"2010","unstructured":"Martire, M. et al. Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals. J. Neurochem. 115 (2), 411\u2013422 (2010).","journal-title":"J. Neurochem"},{"issue":"50","key":"46928_CR20","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1523\/JNEUROSCI.5291-14.2015","volume":"35","author":"T Kimm","year":"2015","unstructured":"Kimm, T., Khaliq, Z. M. & Bean, B. P. Differential Regulation of Action Potential Shape and Burst-Frequency Firing by BK and Kv2 Channels in Substantia Nigra Dopaminergic Neurons. J. Neurosci. 35 (50), 16404\u201316417 (2015).","journal-title":"J. Neurosci."},{"issue":"5","key":"46928_CR21","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1038\/s41380-022-01506-w","volume":"27","author":"S Nisar","year":"2022","unstructured":"Nisar, S. et al. Genetics of glutamate and its receptors in autism spectrum disorder. Mol. Psychiatry. 27 (5), 2380\u20132392 (2022).","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"46928_CR22","doi-asserted-by":"publisher","first-page":"e2208963120","DOI":"10.1073\/pnas.2208963120","volume":"120","author":"DE Mitchell","year":"2023","unstructured":"Mitchell, D. E. et al. Altered integration of excitatory inputs onto the basal dendrites of layer 5 pyramidal neurons in a mouse model of Fragile X syndrome. Proc. Natl. Acad. Sci. U S A. 120 (2), e2208963120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"46928_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/npp.2017.149","volume":"43","author":"MI Carreno-Munoz","year":"2018","unstructured":"Carreno-Munoz, M. I. et al. Potential Involvement of Impaired BK(Ca) Channel Function in Sensory Defensiveness and Some Behavioral Disturbances Induced by Unfamiliar Environment in a Mouse Model of Fragile X Syndrome. Neuropsychopharmacology 43 (3), 492\u2013502 (2018).","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"46928_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/nn.3864","volume":"17","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-\/y) mice. Nat. Neurosci. 17 (12), 1701\u20131709 (2014).","journal-title":"Nat. Neurosci."},{"issue":"1","key":"46928_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s42003-022-03395-9","volume":"5","author":"EV Pedapati","year":"2022","unstructured":"Pedapati, E. V. et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun. Biol. 5 (1), 442 (2022).","journal-title":"Commun. Biol."},{"issue":"1","key":"46928_CR26","doi-asserted-by":"publisher","first-page":"22982","DOI":"10.1038\/s41598-024-72935-6","volume":"14","author":"LE Ethridge","year":"2024","unstructured":"Ethridge, L. E. et al. Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome. Sci. Rep. 14 (1), 22982 (2024).","journal-title":"Sci. Rep."},{"issue":"3","key":"46928_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10548-023-01009-z","volume":"37","author":"Y Takarae","year":"2024","unstructured":"Takarae, Y. et al. EEG Microstates as Markers for Cognitive Impairments in Fragile X Syndrome. Brain Topogr. 37 (3), 432\u2013446 (2024).","journal-title":"Brain Topogr"},{"key":"46928_CR28","doi-asserted-by":"crossref","unstructured":"Liu, R. et al. Reliability of resting-state electrophysiology in fragile X syndrome. Biomark. Neuropsychiatry 9 1\u201319. (2023).","DOI":"10.1016\/j.bionps.2023.100070"},{"issue":"5","key":"46928_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","volume":"27","author":"EM Berry-Kravis","year":"2021","unstructured":"Berry-Kravis, E. M. et al. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nat. Med. 27 (5), 862\u2013870 (2021).","journal-title":"Nat. Med."},{"key":"46928_CR30","doi-asserted-by":"publisher","first-page":"110182","DOI":"10.1016\/j.neuropharm.2024.110182","volume":"262","author":"P Janz","year":"2025","unstructured":"Janz, P. et al. Clinically-probed mechanisms of action in Fragile-X syndrome fail to normalize translational EEG phenotypes in Fmr1 knockout mice. Neuropharmacology 262, 110182 (2025).","journal-title":"Neuropharmacology"},{"key":"46928_CR31","doi-asserted-by":"crossref","unstructured":"Tabatabaee, S. et al. The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca(2+)-Activated K(+) Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing. Pharmaceuticals (Basel) 12 (3), 1\u201312 (2019).","DOI":"10.3390\/ph12030104"},{"issue":"16","key":"46928_CR32","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/bph.13889","volume":"174","author":"D Baker","year":"2017","unstructured":"Baker, D. et al. Big conductance calcium-activated potassium channel openers control spasticity without sedation. Br. J. Pharmacol. 174 (16), 2662\u20132681 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"46928_CR33","doi-asserted-by":"crossref","unstructured":"Pryce, G. et al. Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels. Pharmaceuticals (Basel) 16 (7), 1\u201313 (2023).","DOI":"10.3390\/ph16070972"},{"issue":"1","key":"46928_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41398-022-01796-2","volume":"12","author":"A Kenny","year":"2022","unstructured":"Kenny, A., Wright, D. & Stanfield, A. C. EEG as a translational biomarker and outcome measure in fragile X syndrome. Translational Psychiatry. 12 (1), 35 (2022).","journal-title":"Translational Psychiatry"},{"key":"46928_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13229-021-00425-x","volume":"12","author":"CL Wilkinson","year":"2021","unstructured":"Wilkinson, C. L. & Nelson, C. A. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability. Mol. Autism. 12, 17 (2021).","journal-title":"Mol. Autism"},{"key":"46928_CR36","doi-asserted-by":"crossref","unstructured":"Shields, R. H. et al. Validation of the NIH Toolbox Cognitive Battery in intellectual disability. Neurology, e1229\u2013e1240 (2020).","DOI":"10.1212\/WNL.0000000000009131"},{"issue":"1","key":"46928_CR37","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/s41598-022-09633-8","volume":"12","author":"AE Boggs","year":"2022","unstructured":"Boggs, A. E. et al. Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots. Sci. Rep. 12 (1), 5617 (2022).","journal-title":"Sci. Rep."},{"issue":"6","key":"46928_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ejn.13645","volume":"47","author":"A Dickinson","year":"2018","unstructured":"Dickinson, A. et al. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur. J. Neurosci. 47 (6), 643\u2013651 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"46928_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychires.2021.03.057","volume":"138","author":"EG Smith","year":"2021","unstructured":"Smith, E. G. et al. Sex differences in resting EEG power in Fragile X Syndrome. J. Psychiatr Res. 138, 89\u201395 (2021).","journal-title":"J. Psychiatr Res."},{"issue":"5","key":"46928_CR40","doi-asserted-by":"publisher","first-page":"e0306157","DOI":"10.1371\/journal.pone.0306157","volume":"20","author":"EV Pedapati","year":"2025","unstructured":"Pedapati, E. V. et al. Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity. PLoS One. 20 (5), e0306157 (2025).","journal-title":"PLoS One"},{"issue":"2","key":"46928_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopsycho.2012.11.013","volume":"92","author":"MJ Van der Molen","year":"2013","unstructured":"Van der Molen, M. J. & Van der Molen, M. W. Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol. Psychol. 92 (2), 216\u2013219 (2013).","journal-title":"Biol. Psychol."},{"issue":"2","key":"46928_CR42","doi-asserted-by":"publisher","first-page":"e88451","DOI":"10.1371\/journal.pone.0088451","volume":"9","author":"MJW van der Molen","year":"2014","unstructured":"van der Molen, M. J. W., Stam, C. J. & van der Molen, M. W. Resting-State EEG Oscillatory Dynamics in Fragile X Syndrome: Abnormal Functional Connectivity and Brain Network Organization. PLoS ONE. 9 (2), e88451 (2014).","journal-title":"PLoS ONE"},{"key":"46928_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2018.03.012","volume":"115","author":"JW Lovelace","year":"2018","unstructured":"Lovelace, J. W. et al. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 115, 39\u201348 (2018).","journal-title":"Neurobiol. Dis."},{"key":"46928_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnint.2019.00060","volume":"13","author":"LE Ethridge","year":"2019","unstructured":"Ethridge, L. E. et al. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance. Front. Integr. Neurosci. 13, 60 (2019).","journal-title":"Front. Integr. Neurosci."},{"key":"46928_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nbd.2019.01.002","volume":"124","author":"S Goswami","year":"2019","unstructured":"Goswami, S. et al. Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome. Neurobiol. Dis. 124, 563\u2013572 (2019).","journal-title":"Neurobiol. Dis."},{"key":"46928_CR46","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.nbd.2020.104794","volume":"138","author":"CR Jonak","year":"2020","unstructured":"Jonak, C. R. et al. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 138, 104794 (2020).","journal-title":"Neurobiol. Dis."},{"key":"46928_CR47","doi-asserted-by":"publisher","first-page":"720752","DOI":"10.3389\/fpsyt.2021.720752","volume":"12","author":"KA Razak","year":"2021","unstructured":"Razak, K. A., Binder, D. K. & Ethell, I. M. Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome. Front. Psychiatry. 12, 720752 (2021).","journal-title":"Front. Psychiatry"},{"issue":"1","key":"46928_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s11689-022-09455-9","volume":"14","author":"CR Jonak","year":"2022","unstructured":"Jonak, C. R. et al. Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome. J. Neurodev Disord. 14 (1), 52 (2022).","journal-title":"J. Neurodev Disord"},{"key":"46928_CR49","doi-asserted-by":"publisher","first-page":"106496","DOI":"10.1016\/j.nbd.2024.106496","volume":"195","author":"CR Jonak","year":"2024","unstructured":"Jonak, C. R. et al. Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice. Neurobiol. Dis. 195, 106496 (2024).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"46928_CR50","doi-asserted-by":"publisher","first-page":"e13277","DOI":"10.1111\/desc.13277","volume":"26","author":"SM Weiss","year":"2023","unstructured":"Weiss, S. M. & Marshall, P. J. Anticipation across modalities in children and adults: Relating anticipatory alpha rhythm lateralization, reaction time, and executive function. Dev. Sci. 26 (1), e13277 (2023).","journal-title":"Dev. Sci."},{"key":"46928_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neubiorev.2020.01.005","volume":"111","author":"A Bourgeois","year":"2020","unstructured":"Bourgeois, A. et al. Pulvino-cortical interaction: An integrative role in the control of attention. Neurosci. Biobehav. Rev. 111, 104\u2013113 (2020).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"13","key":"46928_CR52","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/s41386-024-01956-6","volume":"49","author":"C Ferraguto","year":"2024","unstructured":"Ferraguto, C. et al. Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome. Neuropsychopharmacology 49 (13), 2093\u20132104 (2024).","journal-title":"Neuropsychopharmacology"},{"key":"46928_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13229-022-00526-1","volume":"13","author":"V Carter Leno","year":"2022","unstructured":"Carter Leno, V. et al. Infant excitation\/inhibition balance interacts with executive attention to predict autistic traits in childhood. Mol. Autism. 13, 52 (2022).","journal-title":"Mol. Autism"},{"key":"46928_CR54","doi-asserted-by":"publisher","first-page":"101402","DOI":"10.1016\/j.dcn.2024.101402","volume":"68","author":"RA Stanyard","year":"2024","unstructured":"Stanyard, R. A. et al. Aperiodic and Hurst EEG exponents across early human brain development: A systematic review. Dev. Cogn. Neurosci. 68, 101402 (2024).","journal-title":"Dev. Cogn. Neurosci."},{"issue":"8","key":"46928_CR55","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1212\/WNL.0000000000201528","volume":"100","author":"RH Shields","year":"2023","unstructured":"Shields, R. H. et al. Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability. Neurology 100 (8), e778\u2013e789 (2023).","journal-title":"Neurology"},{"issue":"48","key":"46928_CR56","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1523\/JNEUROSCI.0571-23.2023","volume":"43","author":"N Rahmatullah","year":"2023","unstructured":"Rahmatullah, N. et al. Hypersensitivity to Distractors in Fragile X Syndrome from Loss of Modulation of Cortical VIP Interneurons. J. Neurosci. 43 (48), 8172\u20138188 (2023).","journal-title":"J. Neurosci."},{"key":"46928_CR57","doi-asserted-by":"crossref","unstructured":"Aishworiya, R. et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells, 12 (14), 1\u201316 (2023).","DOI":"10.3390\/cells12141920"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46928-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:03:33Z","timestamp":1775649813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46928-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46928-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work was funded by Spinogenix.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11705"}}